BNP Paribas Asset Management
MXCT icon

BNP Paribas Asset Management’s MaxCyte MXCT Stock Holding History

BNP Paribas Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Hold
2,773,554
– – ﹤0.01% 1078
2025
Q4 		$4.3M Buy
+2,773,554
New +$4.43M ﹤0.01% 884

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BNP Paribas Asset Management's MXCT Position: Q1 2026 in Review

BNP Paribas Asset Management held its MaxCyte (MXCT) position steady in Q1 2026 at 2,773,554 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

BNP Paribas Asset Management first reported a position in MXCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.3M in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • BNP Paribas Asset Management held 2,773,554 shares of MaxCyte worth $1.95M as of Q1 2026.
  • BNP Paribas Asset Management left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1078 holding.
  • BNP Paribas Asset Management first reported a position in MaxCyte in Q4 2025 and has held it in 2 quarters since.
  • BNP Paribas Asset Management's MaxCyte position peaked at $4.3M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.